Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.
Age ≥18 years
Patient with historical liver biopsy providing histological evidence of any liver disease or,
Patient undergoing liver biopsy for suspected chronic liver disease with biochemical and/or radiological findings consistent with liver disease or,
Patient with clinical and radiological evidence of cirrhosis (in absence of an alternative aetiology)
Refusal or inability (lack of capacity) to give informed consent.
Age < 18 years
Pregnancy
An active malignancy.
Johannes Gutenberg University Mainz
Lead sponsor
Boehringer Ingelheim
Collaborator
Nordic Bioscience A/S
Collaborator